The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

This effect is currently regarded as a main mechanism ... The most important ongoing or recently completed clinical monoclonal antibody trials in MS are summarized in Table 4.

Both drugs are monoclonal antibodies ... to check for rare but serious side effects, such as brain swelling or bleeding that may result in brain injury or death Both drugs are administered through ...

We demonstrate here that administration of a CD154-specific monoclonal antibody ... to antagonize the anti-rejection effect. Monkeys treated with antibody against CD154 remained healthy during ...

Monoclonal antibody therapy involving four quick injections works “essentially” as well in helping patients recover from COVID-19 as the more cumbersome intravenous infusions, according to a ...